Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2024

van Wyk AC, Lal P, J Ogunbiyi O, Kyokunda L, Hobenu F, Dial C, et al. Multinational, Multicenter Evaluation of Prostate Cancer Tissue in Sub-Saharan Africa: Challenges and Opportunities. JCO Glob Oncol. 2024;10:e2300403.

Morales AE, Gumenick R, Genovese CM, Jang YY, Ouedraogo A, de Garayo MI, et al. Wilms' tumor 1 (WT1) antigen is overexpressed in Kaposi Sarcoma and is regulated by KSHV vFLIP. PLoS Pathog. 2024;20(1):e1011881.

Morse KW, Sun J, Hu L, Bok S, Debnath S, Cung M, et al. Development of Murine Anterior Interbody and Posterolateral Spinal Fusion Techniques. J Bone Joint Surg Am. 2024.

Deng Q, Lakra P, Gou P, Yang H, Meydan C, Teater M, et al. SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisions. Cancer Cell. 2024.

Koh ES, Pandey A, Banuchi VE, Kuhel WI, Tassler A, Scognamiglio T, et al. Depth of invasion as an independent prognostic factor in early-stage oral cavity squamous cell carcinoma. Am J Otolaryngol. 2024;45(3):104269.

Lacunza E, Ahuja A, Coso OA, Abba M, Ramos JC, Cesarman E, et al. Unveiling the role of KSHV-infected human mesenchymal stem cells in Kaposi's sarcoma initiation. J Med Virol. 2024;96(5):e29684.

Barbhaiya M, Taghavi M, Zuily S, Domingues V, Chock EY, Tektonidou MG, et al. Efforts to Better Characterize "Antiphospholipid Antibody Nephropathy" for the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria: Renal Pathology Subcommittee Report. J Rheumatol. 2024;51(2):150-159.

Stenzl A, Armstrong AJ, Sboner A, Ghith J, Serfass L, Bland CS, et al. Artificial INtelligence to Support Informed DEcision-making (INSIDE) for Improved Literature Analysis in Oncology. Eur Urol Focus. 2024;10(6):1011-1018.

Folarin O, Kim D, Gokozan HN, Heymann JJ, Carniello JV, Rosado L, et al. Interobserver agreement and risk of malignancy using the International Academy of Cytology Yokohama System for reporting breast FNA biopsy in a liquid-based exclusive cohort. Cancer Cytopathol. 2024.

Brantley KD, Rosenberg SM, Collins LC, Ruddy KJ, Tamimi RM, Schapira L, et al. Second Primary Breast Cancer in Young Breast Cancer Survivors. JAMA Oncol. 2024;10(6):718-725.